Jiang Yu

603 total citations
13 papers, 501 citations indexed

About

Jiang Yu is a scholar working on Molecular Biology, Genetics and Oncology. According to data from OpenAlex, Jiang Yu has authored 13 papers receiving a total of 501 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Molecular Biology, 6 papers in Genetics and 5 papers in Oncology. Recurrent topics in Jiang Yu's work include Cell death mechanisms and regulation (3 papers), Virus-based gene therapy research (2 papers) and Estrogen and related hormone effects (2 papers). Jiang Yu is often cited by papers focused on Cell death mechanisms and regulation (3 papers), Virus-based gene therapy research (2 papers) and Estrogen and related hormone effects (2 papers). Jiang Yu collaborates with scholars based in United States, China and Canada. Jiang Yu's co-authors include Guru Sonpavde, Weiguo Jian, C. Smith, Mamoun Younes, Steven S. Shen, Seth P. Lerner, Jer‐Tsong Hsieh, Isaac Yi Kim, Gustavo E. Ayala and Shi Huang and has published in prestigious journals such as Cancer, Annals of the New York Academy of Sciences and The Journal of Urology.

In The Last Decade

Jiang Yu

13 papers receiving 489 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jiang Yu United States 7 281 195 139 104 75 13 501
A Batzenschlager France 6 198 0.7× 182 0.9× 88 0.6× 65 0.6× 86 1.1× 46 432
Malkowicz Sb United States 8 224 0.8× 90 0.5× 84 0.6× 32 0.3× 81 1.1× 12 352
David Sidransky United States 6 317 1.1× 84 0.4× 271 1.9× 28 0.3× 52 0.7× 11 512
Marialaura Petroni Italy 16 424 1.5× 43 0.2× 198 1.4× 68 0.7× 54 0.7× 25 624
Ruth Zemer Israel 9 132 0.5× 208 1.1× 124 0.9× 18 0.2× 61 0.8× 18 454
Chih Yi Chen Taiwan 8 328 1.2× 48 0.2× 205 1.5× 37 0.4× 51 0.7× 14 491
P. Athanassiadou Greece 11 159 0.6× 52 0.3× 96 0.7× 26 0.3× 82 1.1× 46 417
Anne‐Marie Houllier France 11 236 0.8× 60 0.3× 205 1.5× 41 0.4× 55 0.7× 15 485
Tomasz Tuziak United States 12 310 1.1× 327 1.7× 156 1.1× 12 0.1× 170 2.3× 13 633

Countries citing papers authored by Jiang Yu

Since Specialization
Citations

This map shows the geographic impact of Jiang Yu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jiang Yu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jiang Yu more than expected).

Fields of papers citing papers by Jiang Yu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jiang Yu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jiang Yu. The network helps show where Jiang Yu may publish in the future.

Co-authorship network of co-authors of Jiang Yu

This figure shows the co-authorship network connecting the top 25 collaborators of Jiang Yu. A scholar is included among the top collaborators of Jiang Yu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jiang Yu. Jiang Yu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

13 of 13 papers shown
1.
Yu, Jiang, et al.. (2014). Interpretation of the guideline of compatibility study of pharmaceutical products and packaging materials——the assessment of experimental data. Zhongguo xin yao zazhi. 940–943. 3 indexed citations
2.
Chen, Tao, Hao Liu, Yanfeng Hu, et al.. (2013). [Value of three risk-stratification criteria in Chinese patients with gastrointestinal stromal tumors].. PubMed. 33(6). 918–22. 1 indexed citations
3.
Yu, Jiang. (2009). BRCA1 gene mutations of hereditary breast cancer from Fujian in China. 1 indexed citations
4.
Sonpavde, Guru, Norihiko Okuno, Heidi L. Weiss, et al.. (2007). Efficacy of Selective Estrogen Receptor Modulators in Nude Mice Bearing Human Transitional Cell Carcinoma. Urology. 69(6). 1221–1226. 52 indexed citations
5.
Yang, Lei, Yanqing Ding, Guoxin Li, et al.. (2007). [Microsatellite analysis and hMLH1/hMSH2 expression detection in young patients with colorectal cancer: value in screening hereditary nonpolyposis colorectal cancer].. PubMed. 27(6). 779–82. 2 indexed citations
6.
Yu, Jiang & Kim Hua Tan. (2006). Attempts for radical innovation in the big emerging countries: the case of China. International Journal of Technology Policy and Management. 6(2). 183–183. 2 indexed citations
7.
Shen, Steven S., C. Smith, Jer‐Tsong Hsieh, et al.. (2006). Expression of estrogen receptors‐α and ‐β in bladder cancer cell lines and human bladder tumor tissue. Cancer. 106(12). 2610–2616. 169 indexed citations
8.
Lerner, Seth P., Guru Sonpavde, Jiang Yu, et al.. (2005). 591: Efficacy of Selective Estrogen Receptor Modulators (SERMS) in a Murine Xenograft Model Bearing Human Bladder Cancer. The Journal of Urology. 173(4S). 161–162. 1 indexed citations
9.
Feng, Dian-xu, et al.. (2002). A Prospective Study of Detection of Pancreatic Carcinoma by Combined Plasma K -ras Mutations and Serum CA19-9 Analysis. Pancreas. 25(4). 336–341. 40 indexed citations
10.
Zhang, Ye, et al.. (2002). From Castration‐Induced Apoptosis of Prostatic Epithelium to the Use of Apoptotic Genes in the Treatment of Prostate Cancer. Annals of the New York Academy of Sciences. 963(1). 191–203. 6 indexed citations
11.
Zhang, Ye, Jiang Yu, Emmanual Unni, et al.. (2002). Monogene and Polygene Therapy for the Treatment of Experimental Prostate Cancers by Use of Apoptotic Genes bax and bad Driven by the Prostate-Specific Promoter ARR 2 PB. Human Gene Therapy. 13(17). 2051–2064. 19 indexed citations
12.
Kellis, M, Michela Marani, Jiang Yu, et al.. (2001). Adenovirus-mediated Bax overexpression for the induction of therapeutic apoptosis in prostate cancer.. PubMed. 61(1). 186–91. 78 indexed citations
13.
He, Li, Jiang Yu, Limin Liu, et al.. (1998). RIZ1, but not the alternative RIZ2 product of the same gene, is underexpressed in breast cancer, and forced RIZ1 expression causes G2-M cell cycle arrest and/or apoptosis.. PubMed. 58(19). 4238–44. 127 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026